Poolbeg Pharma (POLB) Competitors GBX 3.50 -0.05 (-1.41%) As of 07:27 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock POLB vs. MPH, ORPH, IMM, REDX, ETX, HEMO, HVO, SBTX, SAR, and ARECShould you be buying Poolbeg Pharma stock or one of its competitors? The main competitors of Poolbeg Pharma include Mereo BioPharma Group plc (MPH.L) (MPH), Open Orphan (ORPH), ImmuPharma (IMM), Redx Pharma (REDX), e-therapeutics (ETX), Hemogenyx Pharmaceuticals (HEMO), hVIVO (HVO), SkinBioTherapeutics (SBTX), Sareum (SAR), and Arecor Therapeutics (AREC). These companies are all part of the "biotechnology" industry. Poolbeg Pharma vs. Its Competitors Mereo BioPharma Group plc (MPH.L) Open Orphan ImmuPharma Redx Pharma e-therapeutics Hemogenyx Pharmaceuticals hVIVO SkinBioTherapeutics Sareum Arecor Therapeutics Poolbeg Pharma (LON:POLB) and Mereo BioPharma Group plc (MPH.L) (LON:MPH) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, media sentiment, risk, earnings, analyst recommendations, dividends and institutional ownership. Does the media prefer POLB or MPH? In the previous week, Poolbeg Pharma's average media sentiment score of 0.00 equaled Mereo BioPharma Group plc (MPH.L)'saverage media sentiment score. Company Overall Sentiment Poolbeg Pharma Neutral Mereo BioPharma Group plc (MPH.L) Neutral Which has preferable earnings & valuation, POLB or MPH? Poolbeg Pharma is trading at a lower price-to-earnings ratio than Mereo BioPharma Group plc (MPH.L), indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPoolbeg PharmaN/AN/A-£4.50B-£0.01-307.02Mereo BioPharma Group plc (MPH.L)N/AN/AN/A-£128.00N/A Is POLB or MPH more profitable? Mereo BioPharma Group plc (MPH.L)'s return on equity of 0.00% beat Poolbeg Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Poolbeg PharmaN/A -32.56% -21.33% Mereo BioPharma Group plc (MPH.L) N/A N/A N/A Do institutionals & insiders believe in POLB or MPH? 1.5% of Poolbeg Pharma shares are owned by institutional investors. 7.6% of Poolbeg Pharma shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryPoolbeg Pharma and Mereo BioPharma Group plc (MPH.L) tied by winning 3 of the 6 factors compared between the two stocks. Get Poolbeg Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for POLB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding POLB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart POLB vs. The Competition Export to ExcelMetricPoolbeg PharmaBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£24.40M£232.98M£6.09B£2.62BDividend YieldN/A3.80%5.69%5.28%P/E Ratio-307.0295.4685.564,447.37Price / SalesN/A6,168.65535.65100,286.30Price / Cash2.1113.1937.9227.90Price / Book0.00114.5813.038.93Net Income-£4.50B-£90.99M£3.30B£5.89B7 Day Performance-0.68%3.85%4.35%0.71%1 Month Performance-18.60%6.77%9.50%5.82%1 Year Performance-54.55%735.25%85.16%157.47% Poolbeg Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)POLBPoolbeg PharmaN/AGBX 3.50-1.4%N/A-56.3%£24.40MN/A-307.0212Gap DownMPHMereo BioPharma Group plc (MPH.L)N/AN/AN/AN/A£89.76MN/A-0.2150Gap DownORPHOpen OrphanN/AN/AN/AN/A£67.09M£34.71M-25.30179IMMImmuPharmaN/AGBX 11.90-5.2%N/A+519.9%£59.47MN/A-1,337.0813Gap DownREDXRedx PharmaN/AN/AN/AN/A£58.35M£4.20M-150.00101Positive NewsGap UpHigh Trading VolumeETXe-therapeuticsN/AN/AN/AN/A£52.59M£295K-450.0035High Trading VolumeHEMOHemogenyx PharmaceuticalsN/AGBX 1,080-0.2%N/A+94,900.0%£51.05MN/A-596.3614HVOhVIVO1.6181 of 5 starsGBX 7.30-6.4%GBX 23+215.1%-75.2%£50.17M£51.28M470.97N/AGap DownSBTXSkinBioTherapeuticsN/AGBX 14.88-0.8%N/A+34.1%£38.49M£2.68M-1,190.0011SARSareumN/AGBX 25.10-3.5%N/A-28.6%£34.44MN/A-965.383,211ARECArecor TherapeuticsN/AGBX 83.75-3.2%N/A+11.9%£31.62M£5.05M-270.1610 Related Companies and Tools Related Companies MPH Competitors ORPH Competitors IMM Competitors REDX Competitors ETX Competitors HEMO Competitors HVO Competitors SBTX Competitors SAR Competitors AREC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:POLB) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Poolbeg Pharma PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Poolbeg Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
